TGFB1 and neoplasm: The IHC staining results of mice treated tumor specimens showed that PD-1 expression among T lymphocytes in anti-CD25, anti-TGF-β or combination treatment was higher than the control cohort, while these three different treatment showed no significant difference in PD-1 expression.